Tag: preclinical imaging market key players

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Preclinical Imaging Market?

There has been a significant expansion in the size of the preclinical imaging market in the past few years. The market, which is projected to be worth $3.46 billion in 2024, is expected to experience a growth to $3.69 billion in 2025. This represents a compound annual growth rate (CAGR) of 6.5%. The past growth of this market can be attributed to factors such as government initiatives, potentially increasing disease prevalence, the broadening of applications, heightened awareness, and progression into emerging markets.

Expectations are high for robust growth in the preclinical imaging market size in the coming years. It’s estimated to reach a value of $4.81 billion by 2029, advancing at a compound annual growth rate (CAGR) of 6.9%. This growth expected during the forecast period can be credited to the uptake of personalized medicine, progress in molecular imaging, outsourcing of drug development, support from regulatory bodies, and an increase in chronic illnesses. The predominant trends for this forecast period encompass green imaging technologies, technological progression, an escalation in R&D activities, cooperation and collaborations, and real-time imaging.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

What Drivers Are Accelerating Expansion Of The Preclinical Imaging Market?

The escalation of chronic health conditions is predicted to stimulate the expansion of the preclinical imaging market. Chronic illnesses are enduring health conditions typically lasting for three months or longer, often requiring continuous medical care and having a significant effect on the person’s life quality. Preclinical imaging instruments are employed to identify such diseases by visualizing lung function and bone structure. This technique is also applied in chronic disease studies to determine disease progression, enhancing comprehension of the illness. To exemplify, the World Health Organization’s (WHO) 2022 Highlights, published in September 2022, show that a Switzerland-based intergovernmental health organization noted 41 million deaths globally each year, accounting for 74% of all deaths due to Noncommunicable or chronic diseases. The breakdown includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the rise in chronic diseases is a major factor contributing to the growth of the preclinical imaging market.

What Are The Primary Segmentation Parameters In The Preclinical Imaging Market?

The preclinical imagingmarket covered in this report is segmented –

1) By Modality: Optical Imaging Systems; Preclinical Nuclear Imaging Systems; Micro-Magnetic Resonance Imaging Systems; Micro-Ultrasound Systems; Micro-Computed Tomography Systems; Preclinical Photoacoustic Imaging Systems; Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents; Preclinical Nuclear Imaging Reagents; Preclinical MRI Contrast Agents; Preclinical Ultrasound Contrast Agents; Preclinical CT Contrast Agents

3) By End User: Hospital; Diagnostics Center; Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging; Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET); Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems; Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging; Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems; Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging; Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking; MPI For Vascular Imaging

Which Emerging Trends Are Reshaping The Preclinical Imaging Market Landscape?

A significant trend that has emerged in the preclinical imaging market is the introduction of groundbreaking products. Major players in this sector are crafting innovative solutions aimed at maintaining their market dominance. For instance, Fujifilm VisualSonics Inc., a Canada-based company that specializes in the production of imaging systems, unveiled Vevo F2 for preclinical imaging in May 2022. This game-changing product stands out as the premier preclinical imaging system straddling ultra-high to low frequencies (71 MHz–1 MHz) in ultrasounds and photoacoustic imaging. The Vevo F2 is exceptional, thanks to its high-definition image processing technology and an entirely new signal pathway, which enhance image clarity and frame rate. The system is also adaptable to meet particular accuracy needs. Furthermore, it boasts robust attributes such as high-definition image processing technology, an entirely novel signal pathway, customizable system architecture, a vast variety of anatomical targets, and high-resolution imaging capabilities, making it applicable to diverse research fields.

Which Players Are Shaping The Competitive Landscape Of The Preclinical Imaging Market?

Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

What Are The Emerging Regional Trends Driving The Preclinical Imaging Market?

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Browse Through More Reports Similar to the Global Preclinical Imaging Market 2025, By The Business Research Company

3D Medical Imaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report

Brain And Neuroimaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

Breast Imaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/breast-imaging-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Preclinical Imaging Market By 2029?

The preclinical imaging market size has experienced substantial growth in recent years. This market is forecast to increase from $3.46 billion in 2024 to $3.69 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.5%. The expansion witnessed in the past can be ascribed to government initiatives, the rising prevalence of diseases, widening applications, enhanced awareness, and the growth of emerging markets.

The preclinical imaging market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $4.81 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.9%. This forecasted growth can be attributed to the adoption of personalized medicine, progress in molecular imaging, the outsourcing of drug development processes, supportive regulatory measures, and the increasing prevalence of chronic diseases. Prominent developments expected during this period include the introduction of green imaging technologies, continuous technological advancements, an uptick in research and development activities, strategic collaborations and partnerships, and the integration of real-time imaging capabilities.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Which Drivers Are Shaping The Preclinical Imaging Industry’s Market Share?

The projected expansion of the preclinical imaging market is significantly influenced by the rising prevalence of chronic conditions. These are defined as enduring health issues that persist over a prolonged duration, generally exceeding three months. Such conditions frequently necessitate continuous medical care and can substantially diminish an individual’s quality of life. Preclinical imaging instruments are employed to identify chronic diseases through visualization of bone structure and lung function. Additionally, these tools aid in the study of chronic diseases, allowing for the visualization of disease progression and enhancing comprehension. For example, data from the World Health Organization (WHO) 2022 Highlights, published in September 2022 by the Switzerland-based intergovernmental health organization, indicated that Noncommunicable diseases (NCDs), or chronic diseases, were responsible for 41 million deaths annually worldwide, accounting for 74% of all fatalities. Specifically, these included 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the growing incidence of chronic diseases is a primary catalyst for the expansion of the preclinical imaging market.

How Is The Preclinical Imaging Market Segmented?

The preclinical imagingmarket covered in this report is segmented –

1) By Modality: Optical Imaging Systems; Preclinical Nuclear Imaging Systems; Micro-Magnetic Resonance Imaging Systems; Micro-Ultrasound Systems; Micro-Computed Tomography Systems; Preclinical Photoacoustic Imaging Systems; Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents; Preclinical Nuclear Imaging Reagents; Preclinical MRI Contrast Agents; Preclinical Ultrasound Contrast Agents; Preclinical CT Contrast Agents

3) By End User: Hospital; Diagnostics Center; Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging; Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET); Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems; Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging; Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems; Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging; Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking; MPI For Vascular Imaging

What Long-Term Trends Will Shape The Future Growth Of The Preclinical Imaging Industry?

Product innovations are emerging as a significant trend in the preclinical imaging market, with leading companies actively developing advanced products to maintain their market standing. For instance, in May 2022, Fujifilm VisualSonics Inc., a Canada-based biomedical firm specializing in imaging systems, launched the Vevo F2 for preclinical imaging. This groundbreaking product represents the first preclinical ultra-high- to low-frequency (71 MHz–1 MHz) ultrasonic and photoacoustic imaging system. The Vevo F2 integrates HD image processing technology and a completely new signal pathway, contributing to superior image clarity and improved frame rates. Additionally, the system offers customization to meet specific imaging precision requirements. Its features also include HD image processing technology, a completely new signal pathway, customizable system architecture, compatibility with a wide range of anatomical targets, and high-resolution imaging, making it suitable for diverse research applications.

Who Are The Key Multinational Companies Dominating The Preclinical Imaging Market?

Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Preclinical Imaging Market?

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Preclinical Imaging Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Browse Through More Reports Similar to the Global Preclinical Imaging Market 2025, By The Business Research Company

3D Medical Imaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report

Brain And Neuroimaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

Breast Imaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/breast-imaging-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Preclinical Imaging Market In 2029?

Over the past few years, the preclinical imaging market has exhibited robust growth. It is projected to increase from $3.46 billion in 2024 to $3.69 billion in 2025, with a compound annual growth rate (CAGR) of 6.5%. The surge during the historical period can be traced back to government initiatives, the rise in disease prevalence, widened applications, heightened awareness, and growth in emerging markets.

The size of the preclinical imaging market is projected to witness robust growth in the upcoming years, poised to increase to$4.81 billion in 2029 with a compounded annual growth rate (CAGR) of 6.9%. Primary factors driving growth during the forecast period include the rise in personalized medicine, improvements in molecular imaging, outsourcing of drug development, supportive regulations, and an increase in chronic diseases. Key trends projected during this period are the development of green imaging technologies, advancements in technology, an escalation in R&D activities, partnerships and collaborations, and the application of real-time imaging.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

What Are the Core Growth Drivers Propelling the Preclinical Imaging Market Forward?

The preclinical imaging market’s growth is projected to be driven by the rise in chronic illnesses. Chronic diseases, defined as health issues lasting for over three months, generally require continuous medical intervention and significantly influence an individual’s quality of life. To diagnose these persistent ailments, preclinical imaging instruments are employed to depict bone structures and lung functionality. These tools also facilitate the study of disease progression to enhance understanding of chronic diseases. For example, the World Health Organization’s (WHO) 2022 Highlights stated in September 2022 that noncommunicable diseases (NCDs) or chronic diseases globally caused 74% of all deaths, totaling 41 million. These fatalities include 17.9 million from cardiovascular diseases, 9.3 million from cancer, 4.1 million from respiratory diseases, and 2.0 million from diabetes. Consequently, the escalating prevalence of chronic diseases is fueling the enlargement of the preclinical imaging market.

What Segment Types Define the Preclinical Imaging Market Structure?

The preclinical imagingmarket covered in this report is segmented –

1) By Modality: Optical Imaging Systems; Preclinical Nuclear Imaging Systems; Micro-Magnetic Resonance Imaging Systems; Micro-Ultrasound Systems; Micro-Computed Tomography Systems; Preclinical Photoacoustic Imaging Systems; Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents; Preclinical Nuclear Imaging Reagents; Preclinical MRI Contrast Agents; Preclinical Ultrasound Contrast Agents; Preclinical CT Contrast Agents

3) By End User: Hospital; Diagnostics Center; Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging; Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET); Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems; Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging; Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems; Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging; Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking; MPI For Vascular Imaging

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Preclinical Imaging Market?

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Emerging Trends that Are Influencing thePreclinical Imaging Industry Evolution?

There is a growing trend of product innovations in the preclinical imaging market. Primary businesses in this market are creating cutting-edge products to maintain their market presence. For example, Fujifilm VisualSonics Inc., a biomedical firm based in Canada specializing in the manufacture of imaging systems, introduced the VevoF2 for preclinical imaging in May 2022. This groundbreaking product is the inaugural preclinical imaging system which shifts between extremely high and low frequencies (71 MHz-1 MHz), utilizing both ultrasonic and photoacoustic technologies. The Vevo F2 boasts HD image processing technology and a freshly developed signal pathway which enhance image crispness and frame rates. The system can also be tailored to meet specific imaging precision requirements. Furthermore, it comprises features like HD image processing technology, a new signal pathway, system flexibility, a broad variety of anatomical targets, and superior resolution imaging, making it suitable for a range of research uses.

View the full report here:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

What Is the Definition of the Preclinical Imaging Market?

Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12393

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the preclinical imaging industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Preclinical Imaging Market From 2025 To 2029?

The market size of preclinical imaging has seen considerable growth in the past few years. It is expected to increase from $3.46 billion in 2024 and reach $3.69 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The significant growth in the past can be linked to governmental initiatives, a rising incidence of diseases, wider applications, growing consciousness, and expansion into emerging markets.

The market size for preclinical imaging is forecasted to experience notable expansion in the coming years, reaching $4.83 billion in 2029 with a compound annual growth rate (CAGR) of 6.9%. This expected surge in the prediction period can be linked to factors such as the increased acceptance of personalized medicine, advancements in molecular imaging, outsourcing of drug development, supportive regulatory environment, and the escalating prevalence of chronic diseases. Significant trends during the prediction period are anticipated to encompass green imaging technologies, technological progression, augmented R&D activities, collaborations and alliances, and real-time imaging.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Preclinical Imaging Market?

The rising prevalence of chronic diseases is predicted to fuel the expansion of the preclinical imaging market. Chronic diseases are long-term health issues that persist for an extended duration, generally three months or more. These illnesses often necessitate continuous medical care and can dramatically affect an individual’s quality of life. Preclinical imaging tools are utilized to detect chronic diseases, providing visuals of bone structure and lung function. Furthermore, they help in studying chronic diseases, enabling visualization of disease progression and enhancing disease comprehension. For instance, as per the highlights of the World Health Organization (WHO) in September 2022, a Switzerland-based intergovernmental health organization reported that chronic diseases or Noncommunicable diseases (NCDs) cause 41 million deaths annually, accounting for 74% of all deaths worldwide. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the surge in chronic diseases is propelling the growth of the preclinical imaging market.

Which Key Market Segments Comprise the Preclinical Imaging Market and Drive Its Revenue Growth?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Which Areas Are Leading Regions in the Preclinical Imaging Market Expansion Across the Globe?

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Strategic Trends Steering thePreclinical Imaging Market Direction?

A significant emerging trend in the preclinical imaging sector is the creation of innovative products. Leading businesses within the market, such as Fujifilm VisualSonics Inc., a Canada-based biomedical firm specializing in imaging systems, are introducing groundbreaking products to maintain their market stand. For example, Vevo F2, a ground-breaking product designed for preclinical imaging, was released by Fujifilm VisualSonics in May 2022. It is the first ultra-high to low-frequency (71 MHz–1 MHz) ultrasonic and photoacoustic imaging system intended for preclinical use. The Vevo F2 boasts HD image processing capabilities, a brand-new signal pathway, and provides superior image clarity along with higher frame rates. It’s also designed to adapt to specific precision requirements of imaging. The additional features of this system include a fresh signal pathway, the ability to customize the system’s structure, high-resolution imaging, and the capacity to cover a broad range of anatomical targets. This system is apt for diverse research applications.

View the full report here:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

How Is the Preclinical Imaging Market Conceptually Defined?

Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12393

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the preclinical imaging industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Preclinical Imaging Market From 2025 To 2029?

The market size of preclinical imaging has seen considerable growth in the past few years. It is expected to increase from $3.46 billion in 2024 and reach $3.69 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The significant growth in the past can be linked to governmental initiatives, a rising incidence of diseases, wider applications, growing consciousness, and expansion into emerging markets.

The market size for preclinical imaging is forecasted to experience notable expansion in the coming years, reaching $4.83 billion in 2029 with a compound annual growth rate (CAGR) of 6.9%. This expected surge in the prediction period can be linked to factors such as the increased acceptance of personalized medicine, advancements in molecular imaging, outsourcing of drug development, supportive regulatory environment, and the escalating prevalence of chronic diseases. Significant trends during the prediction period are anticipated to encompass green imaging technologies, technological progression, augmented R&D activities, collaborations and alliances, and real-time imaging.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Preclinical Imaging Market?

The rising prevalence of chronic diseases is predicted to fuel the expansion of the preclinical imaging market. Chronic diseases are long-term health issues that persist for an extended duration, generally three months or more. These illnesses often necessitate continuous medical care and can dramatically affect an individual’s quality of life. Preclinical imaging tools are utilized to detect chronic diseases, providing visuals of bone structure and lung function. Furthermore, they help in studying chronic diseases, enabling visualization of disease progression and enhancing disease comprehension. For instance, as per the highlights of the World Health Organization (WHO) in September 2022, a Switzerland-based intergovernmental health organization reported that chronic diseases or Noncommunicable diseases (NCDs) cause 41 million deaths annually, accounting for 74% of all deaths worldwide. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the surge in chronic diseases is propelling the growth of the preclinical imaging market.

Which Key Market Segments Comprise the Preclinical Imaging Market and Drive Its Revenue Growth?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Which Areas Are Leading Regions in the Preclinical Imaging Market Expansion Across the Globe?

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Strategic Trends Steering thePreclinical Imaging Market Direction?

A significant emerging trend in the preclinical imaging sector is the creation of innovative products. Leading businesses within the market, such as Fujifilm VisualSonics Inc., a Canada-based biomedical firm specializing in imaging systems, are introducing groundbreaking products to maintain their market stand. For example, Vevo F2, a ground-breaking product designed for preclinical imaging, was released by Fujifilm VisualSonics in May 2022. It is the first ultra-high to low-frequency (71 MHz–1 MHz) ultrasonic and photoacoustic imaging system intended for preclinical use. The Vevo F2 boasts HD image processing capabilities, a brand-new signal pathway, and provides superior image clarity along with higher frame rates. It’s also designed to adapt to specific precision requirements of imaging. The additional features of this system include a fresh signal pathway, the ability to customize the system’s structure, high-resolution imaging, and the capacity to cover a broad range of anatomical targets. This system is apt for diverse research applications.

View the full report here:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

How Is the Preclinical Imaging Market Conceptually Defined?

Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12393

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of thePreclinical Imaging Market?

The surge in chronic illnesses is anticipated to drive the expansion of the preclinical imaging market in the future. Chronic diseases are long-lasting health issues that often last for three months or more. These conditions typically require continuous medical monitoring and can severely affect an individual’s quality of life. Diagnostic imaging tools, such as preclinical imaging, are utilized to detect these chronic conditions by providing visualizations of the bone structure and lung function. They are also employed to monitor the progression of chronic diseases, advancing our understanding of them. For example, the World Health Organization’s (WHO) 2022 Highlights from September 2022 reported 41 million deaths due to noncommunicable diseases or chronic diseases, accounting for 74% of all global deaths per year. These consisted of 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. As a result, the rise in chronic diseases is fuelling the growth of the preclinical imaging market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

What is the Predicted Annual Growth Rate of thePreclinical Imaging Market Impact Industry Trends by 2034?

The size of the preclinical imaging market has steadily increased over the past few years. Forecasts predict an increase from $3.46 billion in 2024 to $3.69 billion in 2025, representing a compound annual growth rate (CAGR) of 6.7%. This surge in the past period can be traced back to factors such as government schemes, a rise in disease prevalence, widening applications, escalating awareness, and the expansion into emerging markets.

Anticipated significant ascendancy can be set for the preclinical imaging market in the ensuing years, with projections estimating a soar to $4.83 billion in 2029, boasting a compound annual growth rate (CAGR) of 6.9%. This appreciable surge throughout the forecast period could be credited to the increasing adoption of personalized medicine, progress in molecular imaging, outsourcing of drug creation, regulatory reinforcement, and an uptick in chronic conditions. In this forecast duration, prevailing trends may embody sustainable imaging technologies, technological progression, an elevation in research and development initiatives, strategic alliances and partnerships, and the emergence of real-time imaging.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12393

How Are Consumer Market Innovations Shaping the Current and Future Landscape of thePreclinical Imaging Market?

The surge in product innovations is a noticeable trend observed in the preclinical imaging market. Leading players in the market are focusing on creating innovative solutions with an aim to maintain their market standing. In May 2022, an example of such innovation came from Fujifilm VisualSonics Inc., a biomedical firm based in Canada known for its imaging systems. The company introduced the Vevo F2 for preclinical imaging, the first of its kind ultra-high- to low-frequency (71 MHz–1 MHz) ultrasonic and photoacoustic imaging system. The distinguishing features of the Vevo F2 include HD image processing technology, a novel signal pathway, and improved image clarity and frame rates. The new system can be tailored as per the precise needs of imaging. It also boasts features such as a wide range of anatomical targets, high-resolution imaging, HD image processing technology, a unique signal pathway, and customizable system architecture, making it apt for assorted research applications.

Who Are the Key Market Players Influencing the Growth of the Corn and Preclinical Imaging Industry?

Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Which Key Market Segments Comprise the Preclinical Imaging Market and Drive Its Revenue Growth?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Which Regions Are Emerging as Leaders in the Preclinical Imaging Market?

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Preclinical Imaging Maret 2025, By The Business Research Company:

Brain And Neuroimaging Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

Dental Diagnostic Imaging Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dental-diagnostic-imaging-devices-and-equipment-global-market-report

Breast Imaging Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/breast-imaging-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the preclinical imaging market right now?

The size of the preclinical imaging market has seen significant growth in the past few years. This sector is projected to increase from $3.46 billion in 2024 to $3.69 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The expansion during the historical period can be traced back to government initiatives, a surge in the disease prevalence, broadening applications, heightened awareness, and the growth of emerging markets.

How fast Is the preclinical imaging market expected to grow, and what’s its future value?

Growth is projected to be robust in the preclinical imaging market in the coming years, with an expectation to reach $4.83 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 6.9%. The potential surge during the forecast period can be accredited to factors such as the adoption of personalized medicine, advancements in the field of molecular imaging, outsourcing of drug development, supportive regulatory environment, and an increase in chronic diseases. The forecast period is also expected to witness key trends including the emergence of green imaging technologies, technological evolutions, a surge in research and development activities, collaborations and partnerships, and the introduction of real-time imaging.

Get your preclinical imaging market report here!

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

What are the leading drivers of growth in the preclinical imaging market?

The rising prevalence of chronic illnesses is predicted to drive the expansion of the preclinical imaging market. Chronic illnesses are long-lasting health issues that typically persist for three months or more, often requiring continuous medical management and significantly affecting an individual’s quality of life. Preclinical imaging devices are utilized to identify these diseases by visualizing skeletal structures and lung functionalities. They are also employed to analyze how these diseases develop over time and improve understanding of the disease. For example, the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization reported in September 2022, that annually worldwide Noncommunicable diseases (NCDs) or chronic diseases accounted for 41 million deaths, which is 74% of all deaths. Among these 17.9 million are due to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes. As such, the surge in chronic disease is fostering the growth of the preclinical imaging market.

What are the key segments defining the preclinical imaging market?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Who are the key players steering the development of the preclinical imaging market?

Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

What emerging trends are influencing the growth of the preclinical imaging market?

The surge in product innovations is a trend that is rapidly gaining traction in the preclinical imaging market. Top corporations that are active in this market are innovating product designs to maintain a competitive edge. One such example is Fujifilm VisualSonics Inc., a biomedical firm based in Canada that specializes in the production of imaging systems. In May 2022, the company introduced a revolutionary product called Vevo F2, tailored for preclinical imaging. Vevo F2 is the inaugural preclinical imaging system that varies in ultrasound and photoacoustic scanning from ultra-high- to low-frequency (71 MHz–1 MHz). It incorporates HD image processing technology and an entirely new signal pathway, delivering improved image clarity and faster frame rates. The system can also be tailored to meet the exact precision requirements for imaging. Other distinctive features of this system include its customizable system architecture, potential to target various anatomical structures, and high-definition imaging. It is adaptable for use in a range of research scenarios.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12393

Which regions are most influential in expanding the preclinical imaging market?

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Brain And Neuroimaging Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

Dental Diagnostic Imaging Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dental-diagnostic-imaging-devices-and-equipment-global-market-report

Breast Imaging Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/breast-imaging-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Growth Rate of the Preclinical Imaging Market Shape Industry Trends by 2034?

The preclinical imaging market has witnessed strong growth in recent years. It is expected to expand from $3.46 billion in 2024 to $3.69 billion in 2025, at a CAGR of 6.7%. The past growth of this market has been driven by government initiatives, the increasing prevalence of diseases, expanding applications, rising awareness, and market expansion in emerging regions.

The Preclinical Imaging market is forecasted to expand significantly, reaching $4.83 billion in 2029 at a CAGR of 6.9%. Market growth is fueled by the adoption of personalized medicine, advancements in molecular imaging, the rise of drug development outsourcing, regulatory support, and the increasing prevalence of chronic diseases. Emerging trends include the adoption of green imaging technologies, continuous technological advancements, increased R&D activities, growing collaborations and partnerships, and real-time imaging innovations.

How Are the key drivers Contributing to the Expansion of the preclinical imaging Market?

The increase in chronic diseases is projected to drive the preclinical imaging market. Chronic diseases require prolonged medical management and affect quality of life. Preclinical imaging tools are essential in visualizing the progression of diseases like cancer and cardiovascular diseases. For instance, in September 2022, the World Health Organization reported that 74% of all global deaths were from non-communicable diseases, including cardiovascular diseases, cancer, and diabetes. Therefore, the rise in chronic diseases is fueling the preclinical imaging market’s growth.

Get Your Free Sample of the Global Preclinical Imaging Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Who Are the Key Market Players Influencing the Growth of the Preclinical Imaging Industry?

Major companies operating in the preclinical imaging market include:

• Thermo Fisher Scientific Inc._x000D_

• FUJIFILM Visualsonics Inc._x000D_

• Konica Minolta Inc._x000D_

• Agilent Technologies Inc._x000D_

• PerkinElmer Inc._x000D_

What Key Market Trends Are Shaping the Future of the Preclinical Imaging Industry?

In the preclinical imaging market, product innovations are essential for maintaining a competitive edge. For instance, in May 2022, Fujifilm VisualSonics Inc., a Canada-based biomedical company, launched the Vevo F2, the first preclinical ultra-high- to low-frequency ultrasonic and photoacoustic imaging system. The system offers HD image processing technology and customizable architecture, enabling clearer images and better frame rates for various research applications.

Get Instant Access to the Global Preclinical Imaging Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

What Major Market Segments Define the Scope and Growth of the Preclinical Imaging Market?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

Which Regions Are Emerging as Leaders in the Preclinical Imaging Market?

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Defining Features of the Preclinical Imaging Market?

Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases.

Browse Through More Similar Reports By The Business Research Company:

Brain And Neuroimaging Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

Dental Diagnostic Imaging Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dental-diagnostic-imaging-devices-and-equipment-global-market-report

Breast Imaging Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/breast-imaging-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: